Primary cervical choriocarcinoma with germ cell tumor: a case report with literature review

Background: Gestational trophoblastic diseases (GTD) is a series of malignant cancer can be subdivided in pregnancy-associated disease or non-pregnancy choriocarcinoma. The latter among the GTD is extremely rare, particularly primary cervical choriocarcinoma. Case Report: The authors present a case of primary cervical choriocarcinoma with germ cell tumor which is rarely reported. A 46-yearold female visited Beijing Obstetrics and Gynecology hospital because of irregular vaginal bleeding who had undergone radical cervical cancer surgical treatment. After surgery, her symptoms were not visibly changed and the result of pathology suggested cervical cancer. Finally, the authors confirmed its non-gestational origin with ovarian yolk sac tumor by immunohistochemical staining and the level of serum beta-hCG. Fortunately, multiple courses of chemotherapy with BEP regimen were effective for this case. Conclusion: During the course of diagnosis and therapy, immunohistochemical staining and the level of beta-hCG are useful. We could distinguish The tissue origin of this tumor with cervical cancer was distinguished and early diagnosis contributed to the therapy of this disease.

Choriocarcinoma; Primary cervical choriocarcinoma; Diagnosis; Immunohistochemitry; β-hCG.

[1] Udare AS., Mondel PK.: “Extrauterine choriocarcinoma: another un-common primary pelvic retroperitoneal mass seen in adults”. Radio-graphics, 2013, 33, 301.

[2] Morgan J.M., Lurain J.R.: “Gestational trophoblastic neoplasia: an update”. Curr. Oncol. Rep., 2008, 10, 497.

[3] Mitrovic S.L.J., Arsenijevic P.S., Kljakic D., Djuric J.M., Milosavl-jevic M.Z., Protrka Z.M., et al.: “Gestational choriocarcinoma of the cervix”. Arch. Iran. Med., 2014, 17, 783.

[4] Morimura Y., Yazawa M., Hoshi K., Takano Y., Hang X.L., Honda T., et al.: “Uterine cervical clear-cell adenocarcinoma with a chori-ocarcinomatous component: a case report”. J. Obstet. Gynaecol. Res., 1996, 22, 437.

[5] Bel Haj Salah M., Brahim E.B., Zidi Y.S., Tangour M., Kilani H., Chatti-Dey S.: “Mixed germ cell tumor of the ovary with rhab-domyosarcomatous component. A case report”. Ann. Pathol., 2010, 30, 394.

[6] Viana L.S., Tsunoda A.T., Nunes J.S., Fregnani J.H., Vieira M.A., Borges A.K., et al.: “Preservation of pregnancy in a patient with acute abdominal pain secondary to advanced and hemorrhagic yolk sac tumor of the right ovary”. J. Clin. Oncol., 2011, 29, e758.

[7] Goyal L.D., Kaur S., Kawatra K.: “Malignant mixed germ cell tu-mour of ovary—an unusual combination and review of literature”. J. Ovarian Res., 2014, 7, 91.

[8] Even C., Lhommé C., Duvillard P., Morice P., Balleyguier C., Pautier P., et al.: “Ovarian yolk sac tumour: general review”. Bull. Cancer, 2011, 98, 963.

[9] Yang J., Chai L., Fowles T.C., Alipio Z., Xu D., Fink L.M., et al.: “Genome-wide analysis reveals SALL4 to be a major regulator of pluripotency in murine-embryonic stem cells”. Proc. Natl. Acad. Sci. U S A, 2008, 105, 19756.

[10] Miettinen M., Wang Z., McCue P.A., Sarlomo-Rikala M., Rys J., Biernat W., et al.: “SALL4 expression in germ cell and non-germ cell tumors: a systematic immunohistochemical study of 3215 cases”. Am. J. Surg. Pathol., 2014, 38, 410.